WKN: | A112H2 |
ISIN: | US1488061029 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Catalent-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 17. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2019 | 26,53 | 50,50 | 90,35% |
2 | 2020 | 50,50 | 83,50 | 65,35% |
3 | 2024 | 41,05 | 59,93 | 45,99% |
4 | 2017 | 25,16 | 34,36 | 36,57% |
5 | 2021 | 83,50 | 113,00 | 35,33% |
6 | 2016 | 23,05 | 25,16 | 9,15% |
7 | 2015 | 22,88 | 23,05 | 0,74% |
8 | 2025 | 59,93 | 59,93 | 0,00% |
9 | 2023 | 41,99 | 41,05 | -2,24% |
10 | 2018 | 34,36 | 26,53 | -22,79% |
11 | 2022 | 113,00 | 41,99 | -62,84% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2022 | 113,00 | 41,99 | -62,84% |
2 | 2018 | 34,36 | 26,53 | -22,79% |
3 | 2023 | 41,99 | 41,05 | -2,24% |
4 | 2025 | 59,93 | 59,93 | 0,00% |
5 | 2015 | 22,88 | 23,05 | 0,74% |
6 | 2016 | 23,05 | 25,16 | 9,15% |
7 | 2021 | 83,50 | 113,00 | 35,33% |
8 | 2017 | 25,16 | 34,36 | 36,57% |
9 | 2024 | 41,05 | 59,93 | 45,99% |
10 | 2020 | 50,50 | 83,50 | 65,35% |
11 | 2019 | 26,53 | 50,50 | 90,35% |